EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia

Martina Barone iD, Agnese Patuelli, Michele Dicataldo iD, Maria Irno Consalvo, Gabriella Chirumbolo, Lorenza Bandini, Giulia Atzeni iD, Dorian Forte iD, Gianluca Cristiano, Emanuela Ottaviani, Antonio Curti, Francesco Buccisano iD und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26104506 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Martina Barone und 13 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Flow Cytometry, Neoplasm, Residual. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The standardization of multiparameter flow cytometry-based measurable residual disease (MFC-MRD) assessment in acute myeloid leukemia (AML) lacks clear criteria to define leukemia-associated immunophenotypes (LAIPs). In addition, the most specific/sensitive aberrations used to define LAIPs are often partially expressed by the leukemic clone at diagnosis, raising questions about their reliability for accurate MRD quantification. To address this, we investigated whether the quantification of LAIP+ cells reflects residual disease in cases of partial LAIP expression. The following two MFC-MRD approaches were evaluated by comparing their results to RT-qPCR for NPM1 mutations: (1) the LAIP-method, wherein all cells within the patient-specific template created at diagnosis are counted without further gating; (2) the LAIP-based different-from-normal (DfN)-method, wherein cells+ for LAIP-specific aberrant markers are further selected. A total of 125 bone marrow samples from 25 NPM1-mutated AML patients were studied. Our data demonstrate that the LAIP-based DfN-method improves the MFC-MRD accuracy and comparability with molecular MRD. ROC analysis identified cut-offs of 0.034% and 0.095% to discriminate positive/negative results in patients receiving intensive chemotherapy and hypomethylating agents, respectively. We also found distinct accuracy degrees based on the LAIP-specific aberrant markers used for MRD assessment. These results refine the MFC-MRD method and highlight the importance of therapy-specific MRD cut-offs and LAIP classification based on specificity and sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteFlow CytometryNeoplasm, ResidualHumansNucleophosminFemaleMaleMiddle AgedImmunophenotypingAdultMutationNuclear ProteinsAgedBiomarkers, TumorYoung AdultReproducibility of Results

Stichwörter der Autor:innen

acute myeloid leukemialeukemia-associated immunophenotypesmeasurable residual diseasemultiparameter flow cytometry

Substanzen

NucleophosminNPM1 protein, humanNuclear ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", 40138 Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
  • Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

ORCID-Profile: Martina Barone, Michele Dicataldo, Giulia Atzeni, Dorian Forte, Francesco Buccisano, Lucia Catani, Mario Arpinati

Förderung

  • Italian Ministry of Health

Zitieren

APA

Barone, M., Patuelli, A., Dicataldo, M., Irno Consalvo, M., Chirumbolo, G., Bandini, L., Atzeni, G., Forte, D., Cristiano, G., Ottaviani, E., Curti, A., Buccisano, F., Catani, L., & Arpinati, M. (2025). Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104506

Vancouver

Barone M, Patuelli A, Dicataldo M, Irno Consalvo M, Chirumbolo G, Bandini L, et al. Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104506

BibTeX
@article{Barone2025,
  author = {Barone, Martina and Patuelli, Agnese and Dicataldo, Michele and Irno Consalvo, Maria and Chirumbolo, Gabriella and Bandini, Lorenza and Atzeni, Giulia and Forte, Dorian and Cristiano, Gianluca and Ottaviani, Emanuela and Curti, Antonio and Buccisano, Francesco and Catani, Lucia and Arpinati, Mario},
  title = {Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26104506}
}
Kostenlos starten →